Cytomedix Submits 510(k) to FDA for Bone Marrow Aspirate Concentrate Indication for Angel System
01 sept. 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Sept. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Provides Update on Reimbursement Reconsideration Request for Autologous PRP Gel
31 août 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Reports Second Quarter Financial Results
15 août 2011 16h05 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Aug. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Host Second Quarter 2011 Financial Results Conference Call on Tuesday, August 16, 2011
09 août 2011 08h30 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Aug. 9, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
Positive Data Demonstrating AutoloGel Provides Rapid Improvement in Healing of Complex Chronic Wounds Published in Advances in Skin and Wound Care
01 août 2011 08h30 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Completes Two Convertible Note Financings
20 juil. 2011 16h30 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., July 20, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Submits Reimbursement Reconsideration Request to Centers for Medicare & Medicaid Services for Autologous PRP Gel
31 mai 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., May 31, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Reports First Quarter Financial Results
16 mai 2011 16h27 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., May 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the Company), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix to Host First Quarter 2011 Financial Results Conference Call on Tuesday, May 17, 2011
11 mai 2011 07h47 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., May 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today...
Cytomedix Retires All Angel Acquisition Debt With New Loan and Equity Financing
02 mai 2011 08h00 HE
|
Cytomedix, Inc.
GAITHERSBURG, Md., May 2, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...